Kymera Therapeutics, Inc.

Key metrics

Financial performance

Over the last 6 fiscal years Kymera Therapeutics, Inc.'s revenue grew from $2.93M to $39.21M, a compound annual growth rate of 54.0%. Net profit margin expanded from -1405.8% to 794.0% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (575 filings)

Recent press releases

• Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference2026-05-27

  Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference | Kymera Therapeutics, Inc.

• Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses2026-05-15

  Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses | Kymera Therapeutics, Inc.

• Kymera Therapeutics to Participate in Upcoming May Investor Conferences2026-05-06

  Kymera Therapeutics to Participate in Upcoming May Investor Conferences | Kymera Therapeutics, Inc.

• Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week2026-05-05

  Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week | Kymera Therapeutics, Inc.

• Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update2026-04-30

  Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update | Kymera Therapeutics, Inc.

Similar companies

The largest companies sharing Kymera Therapeutics, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).